Toronto — Proteocyte Diagnostics Inc. of Toronto announced their collaboration with Mitacs Accelerate to conduct an economic evaluation of its predictive technology for the early detection of oral cancer. “We’ve partnered with Mitacs before with great success,” said Dr. Mario Thomas, Chief Commercialization Officer of Proteocyte Diagnostics. “The intent of this study is to show the value […]
Read More